The impact of donor-specific anti-HLA antibodies on late kidney allograft failure (Q38003049)

26 August 2017

title

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure (English)

1 reference

26 August 2017

1 reference

Stanley C Jordan

1 reference

26 August 2017

Alexandre Loupy

1 reference

26 August 2017

Gary S Hill

series ordinal

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

Nature Reviews Nephrology

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

348-357

1 reference

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Desensitization Protocols and Their Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Summary of FDA Antibody-Mediated Rejection Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Desensitization in HLA-incompatible kidney recipients and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Deciphering antibody-mediated rejection: new insights into mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

B-cell immunotherapeutics: emerging roles in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Pathology of chronic humoral rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

The spectrum of antibody-mediated renal allograft injury: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Accelerated arteriosclerosis: a form of transplant arteriopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Chronic progressive calcineurin nephrotoxicity: an overstated concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

The quality of life of patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Antibody Testing Strategies for Deceased Donor Kidney Transplantation After Immunomodulatory Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Chronic alloantibody mediated rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Capillary deposition of C4d complement fragment and early renal graft loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Calcineurin inhibitor nephrotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Cyclosporine nephrotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.81

Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.

31 March 2020

1 reference

12 December 2020

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries

1 reference

12 December 2020

Antibodies in transplantation

1 reference

12 December 2020

Cyclosporine nephrotoxicity

1 reference

12 December 2020

Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.81

1 reference

26 August 2017

1 reference